User menu

A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase.

Bibliographic reference Morgan, Hugh P ; Walsh, Martin J ; Blackburn, Elizabeth A ; Wear, Martin A ; Boxer, Matthew B ; et. al. A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase.. In: Biochemical Journal, Vol. 448, no. 1, p. 67-72 (2012)
Permanent URL http://hdl.handle.net/2078/122489
  1. Fothergill-Gilmore Linda A., Michels Paul A.M., Evolution of glycolysis, 10.1016/0079-6107(93)90001-z
  2. Morgan Hugh P., McNae Iain W., Nowicki Matthew W., Hannaert Véronique, Michels Paul A. M., Fothergill-Gilmore Linda A., Walkinshaw Malcolm D., Allosteric Mechanism of Pyruvate Kinase fromLeishmania mexicanaUses a Rock and Lock Model, 10.1074/jbc.m109.079905
  3. Christofk Heather R., Vander Heiden Matthew G., Harris Marian H., Ramanathan Arvind, Gerszten Robert E., Wei Ru, Fleming Mark D., Schreiber Stuart L., Cantley Lewis C., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, 10.1038/nature06734
  4. Vander Heiden M. G., Cantley L. C., Thompson C. B., Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation, 10.1126/science.1160809
  5. Zoraghi Roya, Worrall Liam, See Raymond H., Strangman Wendy, Popplewell Wendy L., Gong Huansheng, Samaai Toufiek, Swayze Richard D., Kaur Sukhbir, Vuckovic Marija, Finlay B. Brett, Brunham Robert C., McMaster William R., Davies-Coleman Michael T., Strynadka Natalie C., Andersen Raymond J., Reiner Neil E., Methicillin-resistantStaphylococcus aureus(MRSA) Pyruvate Kinase as a Target for Bis-indole Alkaloids with Antibacterial Activities, 10.1074/jbc.m111.289033
  6. Nowicki Matthew W., Tulloch Lindsay B., Worralll Liam, McNae Iain W., Hannaert Véronique, Michels Paul A.M., Fothergill-Gilmore Linda A., Walkinshaw Malcolm D., Turner Nicholas J., Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis, 10.1016/j.bmc.2008.03.045
  7. Ayi Kodjo, Min-Oo Gundula, Serghides Lena, Crockett Maryanne, Kirby-Allen Melanie, Quirt Ian, Gros Philippe, Kain Kevin C., Pyruvate Kinase Deficiency and Malaria, 10.1056/nejmoa072464
  8. Zanella A., Bianchi P., Fermo E., Pyruvate kinase deficiency, 10.3324/haematol.11469
  9. Zanella Alberto, Fermo Elisa, Bianchi Paola, Valentini Giovanna, Red cell pyruvate kinase deficiency: molecular and clinical aspects, 10.1111/j.1365-2141.2005.05527.x
  10. Jiang Jian-kang, Boxer Matthew B., Vander Heiden Matthew G., Shen Min, Skoumbourdis Amanda P., Southall Noel, Veith Henrike, Leister William, Austin Christopher P., Park Hee Won, Inglese James, Cantley Lewis C., Auld Douglas S., Thomas Craig J., Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase, 10.1016/j.bmcl.2010.04.015
  11. Vander Heiden Matthew G., Christofk Heather R., Schuman Eli, Subtelny Alexander O., Sharfi Hadar, Harlow Edward E., Xian Jun, Cantley Lewis C., Identification of small molecule inhibitors of pyruvate kinase M2, 10.1016/j.bcp.2009.12.003
  12. Verlinde Christophe L.M.J., Hannaert Véronique, Blonski Casimir, Willson Michèle, Périé Jacques J., Fothergill-Gilmore Linda A., Opperdoes Fred R., Gelb Michael H., Hol Wim G.J., Michels Paul A.M., Glycolysis as a target for the design of new anti-trypanosome drugs, 10.1054/drup.2000.0177
  13. Willson Michèle, Callens Mia, Kuntz Douglas A., Perié Jacques, Opperdoes Fred R., Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei, 10.1016/0166-6851(93)90218-m
  14. Albert Marie-Astrid, Haanstra Jurgen R., Hannaert Véronique, Van Roy Joris, Opperdoes Fred R., Bakker Barbara M., Michels Paul A. M., Experimental andin SilicoAnalyses of Glycolytic Flux Control in Bloodstream FormTrypanosoma brucei, 10.1074/jbc.m502403200
  15. Morgan Hugh P., McNae Iain W., Nowicki Matthew W., Zhong Wenhe, Michels Paul A. M., Auld Douglas S., Fothergill-Gilmore Linda A., Walkinshaw Malcolm D., The Trypanocidal Drug Suramin and Other Trypan Blue Mimetics Are Inhibitors of Pyruvate Kinases and Bind to the Adenosine Site, 10.1074/jbc.m110.212613
  16. DeCamp D, J. Biol. Chem., 261, 4499 (1986)
  17. Vollmer S, J. Biol. Chem., 269, 8082 (1994)
  18. Dombrauckas Jill D., Santarsiero Bernard D., Mesecar Andrew D., Structural Basis for Tumor Pyruvate Kinase M2 Allosteric Regulation and Catalysis†,‡, 10.1021/bi0474923
  19. Painter Jay, Merritt Ethan A., Optimal description of a protein structure in terms of multiple groups undergoing TLS motion, 10.1107/s0907444906005270
  20. Davis I. W., Leaver-Fay A., Chen V. B., Block J. N., Kapral G. J., Wang X., Murray L. W., Arendall W. B., Snoeyink J., Richardson J. S., Richardson D. C., MolProbity: all-atom contacts and structure validation for proteins and nucleic acids, 10.1093/nar/gkm216
  21. Inglese J., Auld D. S., Jadhav A., Johnson R. L., Simeonov A., Yasgar A., Zheng W., Austin C. P., Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries, 10.1073/pnas.0604348103
  22. Shukla S. J., Sakamuru S., Huang R., Moeller T. A., Shinn P., VanLeer D., Auld D. S., Austin C. P., Xia M., Identification of Clinically Used Drugs That Activate Pregnane X Receptors, 10.1124/dmd.110.035105
  23. Carey F, Springer Verlag (2007)
  24. Bakker Barbara M., Michels Paul A. M., Opperdoes Fred R., Westerhoff Hans V., Glycolysis in Bloodstream FormTrypanosoma bruceiCan Be Understood in Terms of the Kinetics of the Glycolytic Enzymes, 10.1074/jbc.272.6.3207
  25. Pendergrass David C., Williams Rachel, Blair James B., Fenton Aron W., Mining for allosteric information: Natural mutations and positional sequence conservation in pyruvate kinase, 10.1080/15216540500531705
  26. Morgan Hugh P., McNae Iain W., Nowicki Matthew W., Hannaert Véronique, Michels Paul A. M., Fothergill-Gilmore Linda A., Walkinshaw Malcolm D., Allosteric Mechanism of Pyruvate Kinase fromLeishmania mexicanaUses a Rock and Lock Model, 10.1074/jbc.m109.079905
  27. Ahmed Alauddin, Taniguchi Nagahiro, Fukuda Hirohiko, Kinoshita Hideki, Inomata Katsuhiko, Kotake Hiroshi, A New and Effective Synthetic Method for the Preparation of the Esters, Peptides, and Lactones Using 3-(5-Nitro-2-oxo-1,2-dihydro-1-pyridyl)-1,2-benzisothiazole 1,1-Dioxide. Synthesis of (±)-(E)-8-Dodecen-11-olide, Recifeiolide, 10.1246/bcsj.57.781
  28. Inglese J., Auld D. S., Jadhav A., Johnson R. L., Simeonov A., Yasgar A., Zheng W., Austin C. P., Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries, 10.1073/pnas.0604348103
  29. Shukla Sunita J., Huang Ruili, Austin Christopher P., Xia Menghang, The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform, 10.1016/j.drudis.2010.07.007
  30. Carey F
  31. Morgan Hugh P., McNae Iain W., Nowicki Matthew W., Zhong Wenhe, Michels Paul A. M., Auld Douglas S., Fothergill-Gilmore Linda A., Walkinshaw Malcolm D., The Trypanocidal Drug Suramin and Other Trypan Blue Mimetics Are Inhibitors of Pyruvate Kinases and Bind to the Adenosine Site, 10.1074/jbc.m110.212613